STOCK TITAN

Vanguard reports 4.34% Hyperfine (HYPR) stake in updated 13G

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

The Vanguard Group filed an amended Schedule 13G reporting beneficial ownership of 3,568,038 shares of Hyperfine Inc common stock, representing 4.34% of the class as of the reported date. Vanguard reports no sole voting or dispositive power, with all voting and dispositive authority shared.

The filing notes an internal realignment effective January 12, 2026, after which certain Vanguard subsidiaries or business divisions are expected to report beneficial ownership separately. Vanguard certifies the shares are held in the ordinary course of business and not for the purpose of changing or influencing control of Hyperfine.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. As of that date, The Vanguard Group, Inc. no longer performs portfolio management services or administers proxy voting. In accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. anticipates that certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that currently have, or are deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment.


SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:01/30/2026

FAQ

What percentage of Hyperfine (HYPR) shares does The Vanguard Group report owning?

The Vanguard Group reports beneficial ownership of 4.34% of Hyperfine’s common stock. This corresponds to a reported position of 3,568,038 shares, based on the company’s outstanding shares, as disclosed in the Schedule 13G/A ownership section.

How many Hyperfine (HYPR) shares does Vanguard have voting and dispositive power over?

Vanguard reports shared voting power over 404,744 shares and shared dispositive power over 3,568,038 shares, with no sole voting or sole dispositive power. These figures define how many shares Vanguard can vote or direct the sale of together with other parties.

Is The Vanguard Group’s Hyperfine (HYPR) stake considered passive or controlling?

Vanguard characterizes its Hyperfine stake as passive. It certifies the securities were acquired and are held in the ordinary course of business and not for the purpose or effect of changing or influencing control of Hyperfine, consistent with Schedule 13G requirements.

Why does the Schedule 13G/A for Hyperfine (HYPR) mention a Vanguard internal realignment?

The filing explains that on January 12, 2026, Vanguard underwent an internal realignment and no longer performs portfolio management or proxy voting. Certain subsidiaries or business divisions are expected to report beneficial ownership separately while pursuing the same investment strategies as before.

Who ultimately benefits from Hyperfine (HYPR) shares reported by The Vanguard Group?

The filing states Vanguard’s clients, including registered investment companies and other managed accounts, have the right to receive dividends and sale proceeds from the Hyperfine shares. It also notes that no single other person’s interest in the reported securities exceeds 5% of the class.

Who signed The Vanguard Group’s Schedule 13G/A related to Hyperfine (HYPR)?

The Schedule 13G/A is signed by Ashley Grim, identified as Head of Global Fund Administration. The signature section certifies that, after reasonable inquiry, the information in the statement is true, complete, and correct as of the stated date.
HYPERFINE

NASDAQ:HYPR

HYPR Rankings

HYPR Latest News

HYPR Latest SEC Filings

HYPR Stock Data

115.63M
78.18M
6.67%
14.46%
2.6%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
GUILFORD